Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
| Autor: | Akinfenwa, Oluwatoyin, Huang, Huey-Jy, Linhart, Birgit, Focke-Tejkl, Margarete, Vrtala, Susanne, Poroshina, Alina, Nikonova, Alexandra, Khaitov, Musa, Campion, Nicholas J., Eckl-Dorna, Julia, Niederberger-Leppin, Verena, Kratzer, Bernhard, Tauber, Peter Anton, Pickl, Winfried F., Kundi, Michael, Campana, Raffaela, Valenta, Rudolf |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
mouse model
Immunology Epitopes T-Lymphocyte Rhinitis Allergic Seasonal hemic and immune systems chemical and pharmacologic phenomena allergy prophylaxis Antigens Plant allergy Mice prevention Desensitization Immunologic Bet v 1 otorhinolaryngologic diseases allergen-specific tolerance induction Immunology and Allergy Animals Peptides T cell epitope-containing peptides Original Research |
| Zdroj: | Frontiers in Immunology |
| ISSN: | 1664-3224 |
| Popis: | IgE-mediated allergy to birch pollen affects more than 100 million patients world-wide. Bet v 1, a 17 kDa protein is the major allergen in birch pollen responsible for allergic rhinoconjunctivitis and asthma in birch pollen allergic patients. Allergen-specific immunotherapy (AIT) based on therapeutic administration of Bet v 1-containing vaccines is an effective treatment for birch pollen allergy but no allergen-specific forms of prevention are available. We developed a mouse model for IgE sensitization to Bet v 1 based on subcutaneous injection of aluminum-hydroxide adsorbed recombinant Bet v 1 and performed a detailed characterization of the specificities of the IgE, IgG and CD4+ T cell responses in sensitized mice using seven synthetic peptides of 31-42 amino acids length which comprised the Bet v 1 sequence and the epitopes recognized by human CD4+ T cells. We then demonstrate that preventive systemic administration of a mix of synthetic non-allergenic Bet v 1 peptides to 3-4 week old mice significantly reduced allergic immune responses, including IgE, IgG, IgE-mediated basophil activation, CD4+ T cell and IL-4 responses to the complete Bet v 1 allergen but not to the unrelated major grass pollen allergen Phl p 5, without inducing Bet v 1-specific allergic sensitization or adaptive immunity. Our results thus demonstrate that early preventive administration of non-allergenic synthetic T cell epitope-containing allergen peptides could be a safe strategy for the prevention of allergen-specific IgE sensitization. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|